Antibiotic developer Next Science emerges on top
Biotechnology start-up Next Science (ASX: NXS) has emerged as one of the top five performing stocks on the ASX with investors recognising a promising new platform technoogy. The company, which raised $35 million to develop its technology to kill bacteria, rose 35 per cent on listing in April, as reported in @AuManufacturing news. Now its…
Details










